Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/07/08 | Not Applicable | Recruiting | Syed Hamza Mufarrih | ||
2025/03/19 | Phase 3 | Not yet recruiting | |||
2024/12/19 | Not Applicable | Recruiting | Arooj Khan | ||
2024/07/25 | N/A | Not yet recruiting | |||
2024/04/16 | Phase 3 | Recruiting | |||
2024/02/01 | Not Applicable | Completed | Fahad Javed Awan | ||
2023/06/28 | Phase 3 | Recruiting | |||
2022/12/01 | Phase 3 | Withdrawn | |||
2022/09/16 | Phase 2 | Active, not recruiting | |||
2022/07/20 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Healthlife of USA | 69517-133 | ORAL | 65 mg in 1 1 | 12/20/2017 | |
Carwin Pharmaceutical Associates, LLC | 15370-102 | ORAL | 9.5 mg in 1 mL | 4/21/2017 | |
Pangea Pharmaceuticals, LLC | 81279-101 | ORAL | 9.5 mg in 1 mL | 12/22/2023 | |
PD-Rx Pharmaceuticals, Inc. | 72789-436 | ORAL | 65 mg in 1 1 | 5/7/2025 | |
Method Pharmaceuticals, LLC | 58657-327 | ORAL | 10 mg in 1 mL | 12/12/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
FEFOL Iron and Folic Acid Delayed Release Capsules blister pack | 12987 | Medicine | A | 8/14/1991 | |
FERROGRAD C tablet blister pack | 66843 | Medicine | A | 4/27/1999 | |
WAGNER PROFESSIONAL Ferro-Sustain Modified Release Tablets | 322181 | Medicine | A | 8/22/2019 | |
FERROSUL FOLIC MR TABS 250 mg/ 300 mcg bottle pack | 343017 | Medicine | A | 9/4/2020 | |
Pharmacy Choice IRON+C ferrous sulfate 325 mg with Ascorbic Acid 500 mg modified release tablet | 395493 | Medicine | A | 9/5/2022 | |
Beauty Collagen + Bone Support | 390521 | Medicine | A | 6/16/2022 | |
Ferro-Max C Iron & Vitamin C modified release tablets | 322081 | Medicine | A | 8/21/2019 | |
Aone Iron + C modified release tablets | 413668 | Medicine | A | 7/18/2023 | |
Hydralyte Sports Orange Flavoured Effervescent Electrolyte Tablets | 346493 | Medicine | A | 10/23/2020 | |
Hydralyte Sports Lemon Lime Flavoured Electrolyte Ice Blocks | 343445 | Medicine | A | 9/14/2020 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
FERINSOL DROPS | mead johnson nutritionals | 00017841 | Drops - Oral | 125 MG / ML | 12/31/1951 |
FERROUS SULFATE TABLETS 300MG | pharmadex laboratories inc. | 01987135 | Tablet - Oral | 300 MG | 12/31/1993 |
LIVRON PLUS AMPOULE | medic laboratory ltée | 00520004 | Liquid - Oral | 36 MG / 10 ML | 12/31/1980 |
ARCHANGELICA COMP. PELLETS | 02232700 | Pellet - Oral | 2 D | 4/10/1998 | |
PILULES DUCASE | produits francais labs inc. | 00166359 | Tablet - Oral | 5 MG | 12/31/1930 |
NOVO-FERROSULFA TAB 300MG(FCT) | novopharm limited | 00021962 | Tablet - Oral | 300 MG | 12/31/1991 |
FERROUS SULFATE ECT 300MG | bionatal drug co | 00332747 | Tablet (Enteric-Coated) - Oral | 300 MG | 12/31/1977 |
FERRUM SULFURICUM-INJEEL LIQ (10D,30D,200D/1.1ML) | 02063107 | Liquid - Oral | 10 D / 1.1 ML | 12/31/1994 | |
HOMEOPATHIC MEDICINE (S#755) DPS 30C | total health centre | 02081121 | Drops - Oral | 30 C / ML | 12/31/1994 |
FERROUS SULFATE TAB 325MG USP | 00722413 | Tablet - Oral | 325 MG | 12/31/1991 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.